NewGenIvf Group (NIVF) Expected to Announce Earnings on Thursday

NewGenIvf Group (NASDAQ:NIVF) will likely be announcing its resultson Thursday, July 30th. Analysts expect NewGenIvf Group to announce earnings of $556.20 per share and revenue of $2.8720 million for the quarter.

NewGenIvf Group (NASDAQ:NIVF) last released its earnings results on Tuesday, March 31st. The company reported ($861.72) earnings per share (EPS) for the quarter. The company had revenue of $1.42 million during the quarter. On average, analysts expect NewGenIvf Group to post $14 EPS for the current fiscal year and $28 EPS for the next fiscal year.

NewGenIvf Group Price Performance

NIVF opened at $0.93 on Wednesday. The business has a fifty day moving average price of $1.84 and a 200 day moving average price of $6.63. The company has a debt-to-equity ratio of 0.16, a current ratio of 3.12 and a quick ratio of 2.98. NewGenIvf Group has a 12 month low of $0.90 and a 12 month high of $568.53.

Insider Transactions at NewGenIvf Group

In related news, major shareholder Financial Lp Hrt purchased 45,847 shares of the company’s stock in a transaction on Friday, May 22nd. The shares were bought at an average cost of $2.97 per share, for a total transaction of $136,165.59. Following the completion of the purchase, the insider directly owned 37,295 shares of the company’s stock, valued at approximately $110,766.15. This trade represents a -536.10% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. 31.80% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Weiss Ratings reiterated a “sell (d)” rating on shares of NewGenIvf Group in a report on Friday. Wall Street Zen upgraded shares of NewGenIvf Group to a “hold” rating in a report on Saturday, July 4th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has an average rating of “Sell”.

NewGenIvf Group Company Profile

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.